Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul;12(7):387-97.
doi: 10.1038/nrcardio.2015.39. Epub 2015 Apr 7.

Epidemiology and pathophysiology of Takotsubo syndrome

Affiliations
Free article
Review

Epidemiology and pathophysiology of Takotsubo syndrome

Yoshihiro J Akashi et al. Nat Rev Cardiol. 2015 Jul.
Free article

Abstract

Takotsubo syndrome is an acute cardiac syndrome first described in 1990 and characterized by transient left ventricular dysfunction affecting more than one coronary artery territory, often in a circumferential apical, mid-ventricular, or basal distribution. Several pathophysiological explanations have been proposed for this syndrome and its intriguing appearance, and awareness is growing that these explanations might not be mutually exclusive. The reversible apical myocardial dysfunction observed might result from more than one pathophysiological phenomenon. The pathophysiology of Takotsubo syndrome is complex and integrates neuroendocrine physiology, potentially involving the cognitive centres of the brain, and including the hypothalamic-pituitary-adrenal axis. Cardiovascular responses are caused by the sudden sympathetic activation and surge in concentrations of circulating catecholamines. The multiple morphological changes seen in the myocardium match those seen after catecholamine-induced cardiotoxicity. The acute prognosis and recurrence rate are now known to be worse than initially thought, and much still needs to be learned about the epidemiology and the underlying pathophysiology of this fascinating condition in order to improve diagnostic and treatment pathways.

PubMed Disclaimer

Comment in

References

    1. Circulation. 2006 Apr 11;113(14):1807-16 - PubMed
    1. Eur Heart J. 2014 Apr;35(15):999-1006 - PubMed
    1. J Am Coll Cardiol. 2010 Jun 1;55(22):2514-6 - PubMed
    1. Chest. 2011 Apr;139(4):887-92 - PubMed
    1. Circ J. 2007 Apr;71(4):565-73 - PubMed

MeSH terms